Thomas Jefferson University
Clinical trials sponsored by Thomas Jefferson University, explained in plain language.
-
Immunotherapy before surgery may shrink head and neck skin cancers, reducing need for disfiguring operations
Disease control TerminatedThis study tests whether giving immunotherapy drugs (cemiplimab alone or with fianlimab) before surgery can shrink advanced basal cell skin cancers on the head and neck. About 70 adults with tumors that are hard to remove without major surgery will receive 2 to 6 infusions before…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
New hope for eye cancer patients: targeted liver treatment shows promise
Disease control OngoingThis study tests a procedure called chemoembolization for people with uveal melanoma (an eye cancer) that has spread to the liver. Doctors inject a chemotherapy drug (BCNU) mixed with an oily substance directly into the liver's blood supply, then block the artery with a sponge-li…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New radiation strategy aims to tackle tough brain tumors
Disease control TerminatedThis early-phase trial tests whether giving higher doses of radiation, guided by special PET/MRI scans, is safe for people with high-risk meningiomas (aggressive or recurrent brain tumors). About 24 adults will receive one of four radiation dose levels to find the highest dose th…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Triple therapy shows promise for aggressive prostate cancer
Disease control OngoingThis early-phase study tested a combination of enzalutamide (a hormone-blocking drug), radiation therapy, and standard hormone therapy in 25 men with intermediate or high-risk prostate cancer. The main goal was to check for side effects and find the best way to give the treatment…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New drug cocktail targets Hard-to-Treat lymphoma
Disease control OngoingThis early-phase study tests the safety of combining three drugs—venetoclax, lenalidomide, and rituximab—in people with follicular or marginal zone lymphoma that has returned or not responded to prior treatment. The goal is to find the best dose and see if the combination is safe…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC
-
Biopsy needle showdown: which tool gets the best tissue sample?
Diagnosis TerminatedThis study aimed to compare two different needles used to take tissue samples from solid masses in the pancreas and digestive tract. The goal was to see which needle provides a more accurate diagnosis. The study was planned for adults needing this procedure, but it was withdrawn …
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 17, 2026 12:04 UTC
-
Smart patch could predict opioid breathing emergencies
Diagnosis ENROLLING_BY_INVITATIONThis study tests a wearable device that listens to breathing sounds to detect and predict when opioids cause dangerously slow or stopped breathing. About 120 adults recovering from surgery will wear the device, and its accuracy will be compared to standard monitors. The goal is t…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 16, 2026 12:53 UTC
-
Could a simple ultrasound replace biopsies for prostate cancer?
Diagnosis OngoingThis study tests whether a special ultrasound, using tiny gas-filled bubbles, can spot prostate cancer without a needle biopsy. About 70 men who are already scheduled for prostate removal will get this ultrasound before surgery. The goal is to see if the bubbles make cancer show …
Phase: PHASE3 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 15, 2026 19:01 UTC
-
New study tests better pain relief for broken ribs
Symptom relief OngoingThis study compares three pain relief methods for people aged 55 and older with three or more broken ribs on one side. Participants will receive either a nerve block with a numbing medicine, a lidocaine drip, or standard pain care including opioids. The goal is to see which appro…
Phase: PHASE4 • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 22, 2026 12:06 UTC
-
Earbud that zaps nerves may calm stressed healthcare workers
Symptom relief OngoingThis study tests whether a device called transcutaneous auricular vagus nerve stimulation (TaVNS) can reduce anxiety and distress in healthcare workers. About 90 participants will use the earbud-like device, and some will also have brain scans to see how it affects brain activity…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 18, 2026 11:48 UTC
-
Antioxidant supplement may boost brain health in MS patients
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether N-acetyl cysteine (NAC), an antioxidant supplement, can improve brain function in people with multiple sclerosis (MS). Researchers will use special PET-MRI scans to measure brain activity and inflammation. About 55 adults with MS who are not planning t…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 11, 2026 12:10 UTC
-
Heart failure patients test natural supplements for better stamina
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether taking ketone or hawthorn supplements for 8 weeks can improve exercise ability and heart function in people with congestive heart failure. About 45 adults with mild to moderate heart failure will be randomly assigned to receive one of the supplements o…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 10, 2026 13:26 UTC
-
Spinal stimulation study aims to restore movement in paralyzed patients
Symptom relief TerminatedThis study tests whether electrical and magnetic stimulation can help people with chronic spinal cord injury move better and feel less stiffness. Ten participants will try different stimulation methods to see which works best. The goal is to improve walking, arm use, and daily li…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 08, 2026 13:05 UTC
-
New online tool aims to help doctors decode prostate cancer genetics
Knowledge-focused OngoingThis study looks at whether a web-based virtual genetics board helps doctors discuss and manage prostate cancer genetics. About 118 healthcare providers, including oncologists and genetic counselors, will use the board and then give feedback through surveys and interviews. The go…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 23, 2026 20:48 UTC
-
Can a culturally tailored education boost cancer screening?
Knowledge-focused TerminatedThis study looks at what helps or hinders people from getting screened for colorectal cancer, focusing on African American, Latinx, and Chinese communities. Researchers will conduct interviews and focus groups to understand cultural beliefs and knowledge gaps. The goal is to crea…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 23, 2026 20:48 UTC
-
Sleep study on cancer patients withdrawn before start
Knowledge-focused TerminatedThis study was designed to track sleep quality in people with head and neck cancer undergoing surgery. Researchers planned to measure factors like time to fall asleep and nighttime awakenings to understand how treatment impacts sleep. The study was withdrawn before enrolling any …
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC